License Issue Fee. In partial consideration for the rights granted to ADAPTIMMUNE hereunder, ADAPTIMMUNE shall pay to LTC a non-refundable, non-creditable license issue fee in the amount of six hundred sixty five thousand dollars ($665,000.00) (“LICENSE ISSUE FEE”). Such LICENSE ISSUE FEE is due and payable by ADAPTIMMUNE to LTC within fifteen (15) days of the EFFECTIVE DATE of this SUB-LICENSE.
Appears in 3 contracts
Samples: Supply Agreement (Adaptimmune Therapeutics PLC), Sub License Agreement (Adaptimmune Therapeutics PLC), Sub License Agreement (Adaptimmune Therapeutics PLC)
License Issue Fee. In partial consideration for the rights granted to ADAPTIMMUNE hereunder, ADAPTIMMUNE shall pay to LTC a non-refundable, non-creditable license issue fee in the amount of six three hundred sixty thirty-five thousand dollars ($665,000.00335,000.00) (“LICENSE ISSUE FEE”). Such LICENSE ISSUE FEE is due and payable by ADAPTIMMUNE to LTC within fifteen (15) days of the EFFECTIVE DATE of ***Portions of this SUB-page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. this LICENSE.
Appears in 2 contracts
Samples: Supply Agreement (Adaptimmune Therapeutics PLC), License Agreement (Adaptimmune Therapeutics PLC)
License Issue Fee. In partial consideration for the rights granted to ADAPTIMMUNE hereunder, ADAPTIMMUNE shall pay to LTC a non-refundable, non-creditable license issue fee in the amount of six hundred sixty five thousand *** dollars ($665,000.00***) (“LICENSE ISSUE FEE”). Such LICENSE ISSUE FEE is due and payable by ADAPTIMMUNE to LTC within fifteen (15) days of the EFFECTIVE DATE of this SUB-LICENSE.
Appears in 2 contracts
Samples: Sub License Agreement (Adaptimmune Therapeutics PLC), Sub License Agreement (Adaptimmune LTD)
License Issue Fee. In partial consideration for the rights granted to ADAPTIMMUNE hereunder, ADAPTIMMUNE shall pay to LTC a non-refundable, non-creditable license issue fee in the amount of six hundred sixty five thousand *** dollars ($665,000.00***) (“LICENSE ISSUE FEE”). Such LICENSE ISSUE FEE is due and payable by ADAPTIMMUNE to LTC within fifteen (15) days of the EFFECTIVE DATE of ***Portions of this SUB-page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. this LICENSE.
Appears in 2 contracts
Samples: License Agreement (Adaptimmune Therapeutics PLC), License Agreement (Adaptimmune LTD)
License Issue Fee. In partial consideration for the rights granted to ADAPTIMMUNE hereunder, ADAPTIMMUNE shall pay to LTC a non-non- refundable, non-creditable license issue fee in the amount of six hundred sixty five thousand *** dollars ($665,000.00***) (“LICENSE ISSUE FEE”). Such LICENSE ISSUE FEE is due and payable by ADAPTIMMUNE to LTC within fifteen (15) days of the EFFECTIVE DATE of this SUB-LICENSE.
Appears in 1 contract
Samples: License Agreement
